Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockadeNicholas McGranahan, Charles Swanton, Rikke Lyngaa et al.|Science|2016Cited by 3.1k
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L. O’Connell, Kirsten Grønbæk, Maria R. Baer et al.|Clinical Cancer Research|2022Cited by 27